Frank Mccormick Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Frank Mccormick is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 83,275 shares of BBIO, which is worth approximately $4.41 Million. The most recent transaction as insider was on Sep 05, 2025, when has been sold 74,000 shares (Common Stock) at a price of $53.16 per share, resulting in proceeds of $3,933,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.3K

8.59% 3M change

93.06% 12M change

Total Value Held $4.41 Million

FRANK MCCORMICK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2025	SELL Open market or private sale	$3,933,839 $53.16 p/Share	74,000 Reduced 47.05%	83,275 Common Stock
Sep 05 2025	BUY Exercise of conversion of derivative security	$882,080 $11.92 p/Share	74,000 Added 32.0%	157,275 Common Stock
Jun 20 2025	BUY Grant, award, or other acquisition	-	6,589 Added 98.76%	83 Common Stock
May 08 2025	SELL Bona fide gift	-	3,000 Reduced 3.76%	76,686 Common Stock
May 07 2025	SELL Bona fide gift	-	33,000 Reduced 29.28%	79,686 Common Stock
Dec 26 2024	SELL Bona fide gift	-	7,400 Reduced 1.57%	464,976 Common Stock
Nov 13 2020	SELL Open market or private sale	$4,290,000 $42.9 p/Share	100,000 Reduced 7.69%	1,200,468 Common Stock

Also insider at

OLMA

Olema Pharmaceuticals, Inc. Healthcare

Director

HLXB

Helix Acquisition Corp. II

Frank Mccormick

Director

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account